2019 Medicaid Medicare Prescription Drug Pricing 
Health Populi
JANUARY 18, 2019
I’m glad to be getting back to health economic issues after spending the last couple of weeks firmly focused on consumers, digital health technologies and CES 2019. He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. ” So much for transparency in 2019.
Health Populi
OCTOBER 8, 2019
The study reviewed reports and articles published between January 1, 2012 and May 15, 2019, dressing the topic of waste across six domains previously identified by the Institute of Medicine: Failure of care delivery, with waste ranging between $102 bn and $166 bn. Political debates in this 2020 U.S. Political debates in this 2020 U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medval Compliance Blog
SEPTEMBER 1, 2021
Recognizing the mounting attention given to hidden fees and surprise billing, on June 24, 2019, former President Trump signed an executive order (EO) directing the Department of Health and Human Services (and additional agencies) to take steps to improve price and quality transparency in healthcare. Medicare Set-Aside Considerations.
Health Populi
MAY 8, 2019
In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. For people enrolled in Medicare Part D, 20% faced over $500 in OOP costs. A cost of $125 or more yields abandonment of at least 50%.
Hall Render
FEBRUARY 24, 2023
Dunleavy adds $9M to budget to address food stamp, Medicaid backlog New study provides snapshot of increase in maternal deaths in Alaska Mental Health Trust Grants $1.6M Dunleavy adds $9M to budget to address food stamp, Medicaid backlog New study provides snapshot of increase in maternal deaths in Alaska Mental Health Trust Grants $1.6M
Health Populi
JUNE 18, 2020
consumers have been supportive of government negotiation for drug pricing since well before the COVID-19 pandemic. A Kaiser Family Foundation poll covered here in Health Populi demonstrated support across party ID back in October 2019. bn between 2019 and 2015 (Part D) and from $4.8 bn for Medicaid. bn to $32.8
Kaiser Health News
AUGUST 12, 2022
First, it would give the federal government the ability to negotiate prices of some drugs purchased by Medicare beneficiaries, a tool that has long been opposed by the drug industry. Never before have we been able to negotiate prescription drug prices. Those prices would take effect in 2026.
Expert insights. Personalized for you.
64 
Let's personalize your content